Suchergebnisse - "Santini, Valeria"

PubPharm (289)

1

Mutations in the splicing factor SF3B1 are linked to frequent emergence of HLA-DRlow/neg monocytes in lower-risk myelodysplastic neoplasms

enthalten in: Leukemia | 2024

von Winter, S. | Schneider, M. | Oelschlaegel, U. | +20

2

Management of adult patients with CMML undergoing allo-HCT : recommendations from the EBMT PH&G Committee

enthalten in: Blood | 2024

von Onida, F. | Gagelmann, N. | Chalandon, Y. | +16

3

Treating acute myelogenous leukemia in patients aged 70 and above : Recommendations from the International Society of Geriatric Oncology (SIOG)

enthalten in: Journal of geriatric oncology | 2024

von Extermann, M. | Artz, A. | Rebollo, M. | +9

4

Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge) : a multinational, randomised, double-blind, placebo-controlled, phase 3 trial

enthalten in: Lancet (London, England) | 2024

von Platzbecker, U. | Santini, V. | Fenaux, P. | +21

ErratumIn: Lancet. 2024 Jan 20;403(10423):248. - PMID 38245245

5

Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1) : a randomised, double-blind, placebo-controlled, phase 2 trial

enthalten in: The Lancet. Haematology | 2024

von Zeidan, A. | Ando, K. | Rauzy, O. | +17

ErratumIn: Lancet Haematol. 2024 Feb 5;:. - PMID 38330978

6

A Nationwide Study of GATA2 Deficiency in Italy Reveals Novel Symptoms and Genotype-phenotype Association

enthalten in: Journal of clinical immunology | 2023

von Roncareggi, S. | Girardi, K. | Fioredda, F. | +25

7

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS) : A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

enthalten in: Blood reviews | 2023

von Stahl, M. | Bewersdorf, J. | Xie, Z. | +45

8

Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts

enthalten in: Leukemia | 2023

von Platzbecker, U. | Santini, V. | Komrokji, R. | +13

9

Biomarkers for predicting responsiveness to decitabine therapy

enthalten in: Europäisches Patentamt | 2023

von FIGUEROA MARIA | PLASSERAUD KRISTEN M | QIN TINGTING | +1

10

A Nationwide Study of GATA2 Deficiency in Italy Reveals Novel Symptoms and Genotype–phenotype Association

enthalten in: Journal of clinical immunology | 2023

von Roncareggi, S. | Girardi, K. | Fioredda, F. | +25

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[29]